The Column Group
North America, California, United States, San Francisco
Description
The Column Group is a venture capital firm dedicated to developing biotechnology companies.
Investor Profile
The Column Group has made 124 investments, with 9 in the past 12 months and 37% as lead.
Stage Focus
- Series A (31%)
- Series B (26%)
- Series C (16%)
- Series D (7%)
- Series Unknown (7%)
- Post Ipo Equity (6%)
- Series E (4%)
- Seed (2%)
- Private Equity (1%)
- Series F (1%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Life Science
- Biopharma
- Genetics
- Medical Device
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
